Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Merkel Cell Carcinoma
100%
Metastatic Carcinoma
85%
Vasculitis
75%
Acute Febrile Neutrophilic Dermatosis
60%
Dermatosis
60%
Drug Eruption
53%
Sentinel Lymph Node
50%
Rickettsia parkeri
50%
Hidradenoma
50%
Rickettsia akari
50%
Cross Sectional Study
50%
Rickettsia rickettsii
50%
Skin Carcinoma
50%
Nummular Dermatitis
50%
Pustulosis
50%
Lentigo
50%
Breast Carcinoma
50%
Tumor Cell
50%
Asenapine
50%
Pityriasis Rosea
50%
Multicentric Reticulohistiocytosis
50%
Microcystic Adnexal Carcinoma
50%
Cancer
50%
Epidermodysplasia verruciformis
50%
Halo Nevus
50%
Isocitrate Dehydrogenase 1
50%
Syringocystadenoma Papilliferum
50%
Angiokeratoma
50%
Porokeratosis
50%
Total Knee Arthroplasty
50%
Nevus
50%
Lichenoid Eruption
50%
Physical Examination
50%
Bullous Pemphigoid
50%
Tivozanib
50%
ANCA Associated Vasculitis
50%
Axitinib
50%
Dermatitis
50%
Nivolumab
50%
Immune Checkpoint Inhibitor
50%
Pemphigoid Gestationis
50%
Blue Nevus
50%
Neoplasm
48%
Spotted Fever
37%
Rickettsia
37%
Corneal Abrasion
37%
Biopsy
36%
Papule
35%
Neuroendocrine Carcinoma
30%
Primary Tumor
30%
Keyphrases
Drug Eruption
53%
Endophthalmitis
50%
Rickettsia Rickettsia
50%
Lentigo
50%
Nummular Eczema
50%
Multiplex Real-time Polymerase Chain Reaction
50%
Rickettsia Rickettsii
50%
Vulvar Melanoma
50%
Multiple Malignancies
50%
Eccrine Spiradenoma
50%
Pustulosis
50%
You Know
50%
Asenapine
50%
Pityriasis Rosea
50%
Histiocytoid Sweet Syndrome
50%
Report Analysis
50%
Rickettsia Akari
50%
Rickettsia Parkeri
50%
Real-time Polymerase Chain Reaction Assay
50%
Immunosuppressive Therapy
50%
Multicentric Reticulohistiocytosis
50%
Microcystic Adnexal Carcinoma
50%
Melanoma Detection
50%
Cutaneous Disease
50%
Syringocystadenoma Papilliferum
50%
Renal Transplant Recipients
50%
Epidermodysplasia Verruciformis
50%
Halo Nevus
50%
Postsurgical
50%
Porokeratosis
50%
Angiokeratoma
50%
Sclerodermatous
50%
Acanthamoeba
50%
Total Knee Arthroplasty
50%
Verrucous
50%
Shave Excision
50%
Nevus Lipomatosus Cutaneous Superficialis
50%
Lichenoid Dermatitis
50%
Nivolumab
50%
Tivozanib
50%
Immune Checkpoint Inhibitor Therapy
50%
Trunk
50%
Bullous Pemphigoid
50%
Axitinib
50%
Pemphigoid Gestationis
50%
Blue Nevus
50%
Histiocytes
50%
Histiocytosis
50%
Systemic Disease
50%
Spotted Fever Group Rickettsiae
37%
